MUMBAI, India, July 7 -- Intellectual Property India has published a patent application (202521095504 A) filed by Lnct University; Mr. Aswini Kumar Das; and Dr. Pradeep Kumar Mohanty on October 04, 2025, for A Pharmaceutical Composition Of Extracts Of Tribulus Terrestris And Chlorophytum Borivilianum For Use In The Treatment Of Depression.
Inventors include Mr. Aswini Kumar Das; and Dr. Pradeep Kumar Mohanty.
The application for the patent was published on July 03, 2026, under issue no. 27/2026.
Abstract: ABSTRACT A PHARMACEUTICAL COMPOSITION OF EXTRACTS OF TRIBULUS TERRESTRIS AND CHLOROPHYTUM BORIVILIANUM FOR USE IN THE TREATMENT OF DEPRESSION 5 10 15 The invention relates to a novel composition and method for treating depression using Indian medicinal plant extracts, specifically Tribulus terrestris fruits and Chlorophytum borivilianum roots. Extracts are prepared and administered to laboratory animals, with significant antidepressant activity demonstrated via forced swim and tail suspension tests. Acute toxicity studies confirm safety. Major active phytoconstituents are identified, providing the scientific basis for the use of these traditional medicines in phytopharmaceutical development targeting depressive disorders.
Disclaimer: Curated by HT Syndication.
